Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,606.49
(
-0.27%
)
US TECH 100
23,763.96
(
-0.13%
)
Dow Jones
46,021.43
(
-0.44%
)
Brent Oil
103.80
(
-0.61%
)
Bitcoin
70,608.99
(
1.02%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Preciouslife1

Send PM Follow Ignore
Followers 90
Posts 20290
Boards Moderated 3
Alias Born 11/05/2005

Preciouslife1

Re: DewDiligence post# 70050

Saturday, 12/13/2008 12:31:04 AM

Saturday, December 13, 2008 12:31:04 AM

Post# of 257262
Wow..>>>How Teva expects to get around GILD’s patent on Viread, the other constituent of Truvada, is unclear.<<<

Dew, Teva always does all their DD, inside and out and this
one will be a dogfight imho....two powerhouses presenting
the science, the patents, clinical trial data, in a high
stakes game in court....wow.

Peace.....PL1
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now